Daewoong Pharmaceutical and Namyangju Hanyang Hospital Establish Namyangju's First "AI Smart Ward"

120 Beds Including Dedicated Wards for Critically Ill Patients

Daewoong Pharmaceutical announced on November 20 that, in partnership with Namyangju Hanyang Hospital, it has introduced the region's first artificial intelligence (AI)-based smart ward monitoring system, "thynC."

A nurse applying an oxygen saturation monitor device linked with Think to a patient. Daewoong Pharmaceutical

With the recent increase in the elderly population, the number of critically ill and chronic patients has been steadily rising, leading to a growing need for systems that can more precisely monitor and manage their conditions. However, traditional methods of measuring vital signs require medical staff to manually check data at set intervals and record it on charts, making it difficult to respond quickly to real-time changes.

To address this, Namyangju Hanyang Hospital has implemented thynC in a total of 120 beds, including the infectious disease intensive care unit and dedicated wards for critically ill patients. The system automatically detects vital signs 24 hours a day and immediately sends alerts to medical staff when abnormalities are detected, establishing a real-time monitoring system. Through this, the hospital aims to further enhance its university hospital-level care environment and solidify its status as a key regional hospital.

The infectious disease intensive care unit and dedicated wards for critically ill patients where thynC has been applied are areas where patients with frequent condition changes and requiring intensive management are admitted. Patients and caregivers can feel reassured by the presence of "medical staff available around the clock," while medical staff can now detect even subtle abnormalities quickly, enabling faster and more accurate clinical responses.

Previously, when approaching patients at high risk of infection, medical staff had to wear protective equipment, which increased their workload. However, with thynC, key vital signs can be monitored remotely, minimizing unnecessary contact, reducing the work burden on medical staff, and still ensuring patient safety.

Namyangju Hanyang Hospital expects that the introduction of thynC will contribute to improving overall medical quality by enhancing patient convenience, increasing work efficiency for medical staff, improving the quality of medical services, and advancing predictive emergency response capabilities.

Jang Jinhyuk, Director of Namyangju Hanyang Hospital, stated, "Introducing the first AI smart bed monitoring system in Namyangju is an important milestone in realizing our hospital's vision of becoming a hospital of choice comparable to university hospitals and a source of pride for local residents. We will continue to grow as a future-oriented hospital dedicated to the safety and recovery of each and every patient."

Cho Byungha, Head of Digital Healthcare Business at Daewoong Pharmaceutical, said, "This case at Namyangju Hanyang Hospital is a leading example of digital healthcare innovation. We will continue to work with pioneering medical institutions to promote the spread of digital healthcare technologies and contribute to creating a safe and efficient future medical environment."

Meanwhile, Namyangju Hanyang Hospital is a general hospital with approximately 300 beds, operating 18 medical departments and 7 specialized centers, and serves as a key institution for the treatment of serious illnesses and health management in the local community.

This content was produced with the assistance of AI translation services.